Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
McKenzie, Thomas (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S397000, C546S086000, C548S311700
Reexamination Certificate
active
07125886
ABSTRACT:
The subject invention provides useful and novel 5-HT3 antagonists. The subject invention also provides methods for synthesizing the compounds of invention. The invention also provides methods for the treatment of irritable bowel syndrome and other such conditions.
REFERENCES:
patent: 5183820 (1993-02-01), Coates et al.
patent: 5202343 (1993-04-01), Coates et al.
patent: 5401750 (1995-03-01), Varasi et al.
patent: 6284770 (2001-09-01), Mangel et al.
patent: 6770655 (2004-08-01), Zhang et al.
patent: 3740352 (1987-11-01), None
patent: 0 353 983 (1990-02-01), None
patent: 2 209 335 (1989-05-01), None
Becker Cyrus
Druzgala Pascal
Pfister Jurg R.
Zhang Xiaoming
Aryx Therapeutics
McDonnell Boehnen & Hulbert & Berghoff LLP
McKenzie Thomas
Rahmani Niloofar
LandOfFree
5-HT3 receptor antagonists and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT3 receptor antagonists and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT3 receptor antagonists and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3689250